ICON plc to Present at the Baird 2024 Global Healthcare Conference
ICON plc (NASDAQ: ICLR), a leading healthcare intelligence and clinical research organization, has announced its participation in the Baird 2024 Global Healthcare Conference. Dr. Steve Cutler, CEO of ICON, is scheduled to present on Tuesday, September 10, 2024, at 3:45 pm ET.
This event marks an important opportunity for ICON to showcase its expertise and insights in the healthcare sector. Investors and interested parties can access the live webcast through the 'Events' section of ICON's Investor Relations website. Any updates or changes to the event details will be communicated via the same platform, ensuring stakeholders remain informed.
ICON's participation in this prestigious conference underscores its commitment to engaging with the investment community and sharing its vision for the future of healthcare intelligence and clinical research.
ICON plc (NASDAQ: ICLR), un'organizzazione leader nell'intelligence sanitaria e nella ricerca clinica, ha annunciato la sua partecipazione alla Baird 2024 Global Healthcare Conference. Dr. Steve Cutler, CEO di ICON, è programmato per presentare martedì 10 settembre 2024, alle 15:45 ET.
Questo evento rappresenta un'importante opportunità per ICON di mostrare la propria esperienza e intuizioni nel settore sanitario. Gli investitori e le parti interessate possono accedere alla diretta web attraverso la sezione 'Eventi' del sito web delle relazioni con gli investitori di ICON. Eventuali aggiornamenti o modifiche ai dettagli dell'evento verranno comunicati tramite la stessa piattaforma, garantendo che i portatori di interesse rimangano informati.
La partecipazione di ICON a questo prestigioso convegno sottolinea il suo impegno a coinvolgere la comunità degli investitori e a condividere la propria visione per il futuro dell'intelligence sanitaria e della ricerca clinica.
ICON plc (NASDAQ: ICLR), una organización líder en inteligencia de salud e investigación clínica, ha anunciado su participación en la Baird 2024 Global Healthcare Conference. Dr. Steve Cutler, CEO de ICON, está programado para presentar el martes 10 de septiembre de 2024, a las 3:45 pm ET.
Este evento representa una importante oportunidad para que ICON muestre su experiencia y conocimientos en el sector de la salud. Los inversores y las partes interesadas pueden acceder a la transmisión en vivo a través de la sección 'Eventos' del sitio web de relaciones con inversores de ICON. Cualquier actualización o cambio en los detalles del evento se comunicará a través de la misma plataforma, asegurando que las partes interesadas se mantengan informadas.
La participación de ICON en esta prestigiosa conferencia subraya su compromiso con la comunidad inversora y su deseo de compartir su visión sobre el futuro de la inteligencia en salud y la investigación clínica.
ICON plc (NASDAQ: ICLR), 선도적인 건강 관리 정보 및 임상 연구 조직이, Baird 2024 Global Healthcare Conference에 참가한다고 발표했습니다. Dr. Steve Cutler, ICON의 CEO는 2024년 9월 10일 화요일, 오후 3:45 ET에 발표할 예정입니다.
이 이벤트는 ICON이 건강 관리 분야에서의 전문성과 통찰력을 보여줄 중요한 기회를 제공합니다. 투자자 및 이해관계자는 ICON의 투자자 관계 웹사이트의 '이벤트' 섹션을 통해 생중계에 접근할 수 있습니다. 이벤트 세부 사항에 대한 업데이트나 변경 사항은 같은 플랫폼을 통해 전달되어 이해관계자들이 정보를 받을 수 있도록 보장합니다.
ICON의 이 저명한 회의에 대한 참여는 투자 커뮤니티와의 소통 및 건강 관리 정보 및 임상 연구의 미래에 대한 비전을 공유하려는 의지를 강조합니다.
ICON plc (NASDAQ: ICLR), une organisation de recherche clinique et d'intelligence en santé de premier plan, a annoncé sa participation à la Baird 2024 Global Healthcare Conference. Dr. Steve Cutler, PDG d'ICON, doit présenter le mardi 10 septembre 2024, à 15h45 ET.
Cet événement représente une occasion importante pour ICON de démontrer son expertise et ses perspectives dans le secteur de la santé. Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct via la section 'Événements' du site Internet des relations investisseurs d'ICON. Toute mise à jour ou modification des détails de l'événement sera communiquée via la même plateforme, garantissant que les parties prenantes restent informées.
La participation d'ICON à cette conférence prestigieuse souligne son engagement à dialoguer avec la communauté des investisseurs et à partager sa vision pour l'avenir de l'intelligence en santé et de la recherche clinique.
ICON plc (NASDAQ: ICLR), ein führendes Unternehmen für Gesundheitsintelligenz und klinische Forschung, hat seine Teilnahme an der Baird 2024 Global Healthcare Conference bekannt gegeben. Dr. Steve Cutler, CEO von ICON, wird voraussichtlich am Dienstag, den 10. September 2024, um 15:45 Uhr ET präsentieren.
Diese Veranstaltung stellt eine wichtige Gelegenheit für ICON dar, seine Expertise und Einblicke im Gesundheitssektor zu zeigen. Investoren und interessierte Parteien können über den Bereich 'Events' der Investor-Relations-Website von ICON auf den Live-Stream zugreifen. Änderungen oder Aktualisierungen zu den Veranstaltungsdetails werden über dasselbe Medium kommuniziert, um sicherzustellen, dass die Beteiligten informiert bleiben.
Die Teilnahme von ICON an dieser renommierten Konferenz unterstreicht das Engagement des Unternehmens, mit der Investorencommunity in Kontakt zu treten und seine Vision für die Zukunft der Gesundheitsintelligenz und klinischen Forschung zu teilen.
- None.
- None.
Any changes to this event and links to the live webcast will be posted on the Investor section of our website under “Events”.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in
This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.
Source: ICON plc
ICON/ICLR-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20240903058172/en/
Kate Haven Vice President Investor Relations +1 888 381 7923
Source: ICON plc
FAQ
When is ICON plc (ICLR) presenting at the Baird 2024 Global Healthcare Conference?
Who will be representing ICON plc (ICLR) at the Baird 2024 Global Healthcare Conference?
How can investors access ICON plc's (ICLR) presentation at the Baird 2024 Global Healthcare Conference?
What type of organization is ICON plc (ICLR)?